SCHEMBL7242510

SCHEMBL7242510

c1ccc(COc2ccc(OCCCCN3CCCCC3Cc3ccccc3)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.57
ALDH1A1 P00352 3/20 0.57
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
HTT P42858 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
NPY1R P25929 1/20 0.56
LTA4H P09960 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.52
HRH3 Q9Y5N1 6/20 0.50
KCNH2 Q12809 1/20 0.48
MCHR1 Q99705 1/20 0.48
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.46
TMEM97 Q5BJF2 1/20 0.46
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243458 0.93 TMEM97 (0.53) KDM4EALDH1A1NPC1RAB9AHTT
SCHEMBL7245268 0.91 TMEM97 (0.52) NPC1RAB9AHRH3KCNH2TMEM97
Bromide SCHEMBL5888803 0.91 TMEM97 (0.52) KDM4EALDH1A1NPC1RAB9AHTT
Hydrochloric Acid SCHEMBL7250296 0.91 ESR1 (0.51) KDM4EALDH1A1NPC1RAB9AHTT
Bromide SCHEMBL7251227 0.90 TMEM97 (0.51) NPC1RAB9AHRH3KCNH2TMEM97
SCHEMBL7250983 0.89 TMEM97 (0.58) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
Bromide SCHEMBL5888830 0.88 TMEM97 (0.56) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL7244449 0.87 ESR1 (0.52) KDM4EALDH1A1NPC1RAB9AHTT
SCHEMBL7242932 0.86 LTA4H (0.46) KDM4EALDH1A1NPC1RAB9AHTT
SCHEMBL5888840 0.85 TMEM97 (0.57) LTA4HTMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534525-B1 Method of using 2- substituted piperidine analogs as selectively active antagonist of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, WARNER-LAMBERT & COMPANY 2003-03-18 US disclosed
US-6124317-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
WO-1997023215-A1 2-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed